Home / News / The Merck plant in Corsier: at the forefront of the fight against cancer!

News

The Merck plant in Corsier: at the forefront of the fight against cancer!

The Corsier-sur-Vevey site, which employs more than 500 collaborators, confirms the particular importance of its activities from a human as well as an economic point of view. The avelumab molecule produced a this site will soon be used to treat a rare skin cancer, since the American authorities have given the Merck group a marketing authorization for avelumab for the treatment of the Merkel-cell carcinoma.
It is an important step for patients with this rare type of skin cancer, which has a high mortality rate as it is associated with a poor prognosis. This approbation is also rejoicing economic news for the Geneva Lake area because avelumab, a molecule found thanks to Merck’s research, is exclusively produced on the Vevey sites (in the case of the active ingredient) and Aubonne (in the case of the finished product) for the entire world.

www.merck.ch